The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 24, 2023

Filed:

Aug. 25, 2020
Applicant:

Great Lakes Neurotechnologies Inc., Cleveland, OH (US);

Inventors:

Joseph P. Giuffrida, Hinckley, OH (US);

Dustin A. Heldman, Shaker Heights, OH (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61B 5/11 (2006.01); G16H 40/67 (2018.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); A61B 5/389 (2021.01); A61B 5/00 (2006.01); A61B 5/316 (2021.01);
U.S. Cl.
CPC ...
A61B 5/4839 (2013.01); A61B 5/0022 (2013.01); A61B 5/1101 (2013.01); A61B 5/1123 (2013.01); A61B 5/389 (2021.01); A61B 5/4082 (2013.01); A61B 5/6826 (2013.01); A61B 5/742 (2013.01); A61M 5/14244 (2013.01); A61M 5/1723 (2013.01); G16H 40/67 (2018.01); A61B 5/316 (2021.01); A61B 5/6824 (2013.01); A61B 5/6825 (2013.01); A61B 5/7239 (2013.01); A61B 5/7242 (2013.01); A61B 2562/0219 (2013.01);
Abstract

The present invention relates to a movement disorder monitor with high sensitivity, and a method of measuring the severity of a subject's movement disorder. The present invention additionally relates to a drug delivery system for dosing a subject in response to the increased severity of a subject's symptoms. The present invention provides for a system and method, which can accurately and repeatably quantify symptoms of movements disorders, accurately quantifies symptoms utilizing both kinetic information and/or electromyography (EMG) data, that can be worn continuously to provide continuous information to be analyzed as needed by the clinician, that can provide analysis in real-time, that allows for home monitoring of symptoms in subject's with these movement disorders to capture the complex fluctuation patterns of the disease over the course of days, weeks or months, that maximizes subject safety, and that provides substantially real-time remote access to data by the clinician or physician.


Find Patent Forward Citations

Loading…